SCHEMBL11625976

SCHEMBL11625976

CCCC(c1ccc(-c2ccc(Cl)cc2)cc1)N1CCN(CCOC)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.44
▸ POLB P06746 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ HRH3 Q9Y5N1 2/20 0.44
▸ MAPT P10636 1/20 0.42
▸ HRH1 P35367 4/20 0.42
▸ DRD3 P35462 3/20 0.42
▸ KCNH2 Q12809 3/20 0.42
▸ CHRM2 P08172 2/20 0.42
▸ ADRA2A P08913 2/20 0.42
▸ HRH2 P25021 2/20 0.42
▸ HTR2A P28223 2/20 0.42
▸ ADRA1A P35348 2/20 0.42
▸ HTR2B P41595 2/20 0.42
▸ USP2 O75604 2/20 0.42
▸ CYP2D6 P10635 2/20 0.42
▸ ABCB11 O95342 1/20 0.42
▸ DRD2 P14416 1/20 0.42
▸ ADRA2B P18089 1/20 0.42
▸ ADRA2C P18825 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11627583 0.93 HRH3 (0.53) KDM4EHRH3MAPTHRH1DRD3
SCHEMBL11623365 0.92 HRH3 (0.49) KDM4EHRH3MAPTHRH1DRD3
SCHEMBL11627527 0.85 HRH3 (0.45) POLBHRH3HRH1DRD3KCNH2
SCHEMBL10503605 0.83 KDM4E (0.48) KDM4EHRH3HRH1DRD3KCNH2
SCHEMBL11624816 0.78 HRH3 (0.55) KDM4EPOLBHRH3HRH1DRD3
SCHEMBL11625094 0.77 HRH3 (0.51) KDM4EPOLBHRH3HRH1DRD3
SCHEMBL11627158 0.77 CYP2D6 (0.54) HRH3CYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL11623216 0.75 CYP3A4 (0.48) HRH3HTR2ACYP3A4CHRM1MC4R
SCHEMBL13949605 0.74 DRD3 (0.71) KDM4ESMN1; SMN2HRH3HRH1DRD3
SCHEMBL11968882 0.72 HRH3 (0.56) POLBHRH3MAPTDRD3KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4125612-A N-1-(p-Biphenylalkyl)piperazines and their use as anti-inflammatory agents SCHERING CORPORATION (US) 1978-11-14 — — US disclosed
Send feedback